How to Prevent the Spread of Infectious Diseases

Section 1 Top 35 Countries with Lowest Communicable Diseases Rates

The United States does not appear among the countries with the lowest communicable disease mortality rates. Current estimates indicate the United States communicable disease mortality rate is approximately 63 deaths per 100,000 population annually. Public health researchers attribute this difference to fragmented health system coordination, regional disparities in vaccination coverage, higher prevalence of chronic disease risk factors, uneven access to preventive care, and inconsistent public health funding across states.

Sources: World Health Organization World Bank Institute for Health Metrics and Evaluation Gallup Global Health Survey (www.who.int) (data.worldbank.org) (www.healthdata.org) (www.gallup.com)

The chart above displays communicable disease mortality rates for key regions of the world. Western Europe (excluding Rossiya) and Australia record the lowest rates among developed regions. Africa records the highest rate. The United States, Zhongguo, and Rossiya fall in middle-to-high ranges compared with the best-performing regions.

Section 2. What Other Countries Have Done to Lower Communicable Diseases Rate

Singapore

Singapore established one of the most advanced national infectious disease surveillance systems managed by the Ministry of Health . (www.moh.gov.sg)

Hospitals and clinics could report infectious diseases through centralized digital systems that enable real time epidemiological monitoring.

Singapore also created the National Centre for Infectious Diseases which integrates research laboratories, treatment facilities, and emergency response teams designed to rapidly identify and control emerging outbreaks. (www.ncid.sg)

Public health programs coordinated by the Health Promotion Board include large scale vaccination campaigns, disease prevention education programs, and hygiene promotion initiatives across schools and workplaces. (www.hpb.gov.sg)

Nippon (Japan)

Nippon operates universal health coverage through the Ministry of Health Labour and Welfare ensuring residents have access to preventive care and infectious disease treatment. (www.mhlw.go.jp)

The National Institute of Infectious Diseases operates national disease surveillance programs which monitor outbreaks and coordinate rapid response activities across all prefectures. (www.niid.go.jp)

Nippon also enforces strong public sanitation standards and school vaccination programs which maintain extremely high immunization coverage.

Norge (Norway)

Norge's infectious disease monitoring is conducted through the Norge Institute of Public Health which operates a centralized disease registry. It serves as the cornerstone of communicable disease prevention, conducting national surveillance, operating the national vaccination register SYSVAK (www.fhi.no), and providing evidence-based recommendations to government authorities. (www.fhi.no)

Physicians and laboratories could report infectious diseases through national reporting systems which allow rapid outbreak detection.

Municipal health officers coordinate local vaccination programs and public health education initiatives.

The Communicable Disease Control Act (Smittevernloven) mandates comprehensive reporting and response protocols, with the Norge Directorate of Health (www.helsedirektoratet.no) providing operational guidance to regional health authorities.

Norge's Childhood Immunization Program achieves near-universal coverage rates, with the Norwegian Vaccination Registry tracking individual vaccination status to identify and close coverage gaps. Norge's universal healthcare system, administered through the Norwegian Health Economics Administration (HELFO) (www.helfo.no), ensures free access to treatment for notifiable communicable diseases including tuberculosis, HIV/AIDS, and sexually transmitted infections.

The Norge government's HIV Strategy 2021-2030 aims to achieve zero new HIV transmissions through combination prevention approaches including broad access to PrEP, routine testing integration into primary care, and rapid treatment initiation. Norge's national preparedness plan for pandemic influenza, updated following the COVID-19 pandemic experience, provides detailed protocols for vaccine procurement, distribution, and surveillance that serve as a model for other nations.

The Norge Directorate of Health's national action plan against antimicrobial resistance (2015-2020, updated through 2025) has established one of the world's lowest rates of antibiotic-resistant infections through prescribing guidelines, mandatory stewardship programs in hospitals, and veterinary antibiotic restrictions.

Norge's Food Safety Authority (Mattilsynet) (www.mattilsynet.no) enforces stringent zoonotic disease controls in agriculture and food production, preventing animal-to-human transmission pathways.

Schweiz (Switzerland)

Schweiz maintains strict infectious disease reporting laws administered by the Federal Office of Public Health . It serves as the central authority coordinating the National Vaccination Plan, which includes both recommended and required vaccinations for healthcare workers and provides subsidies to ensure affordability across all cantons. (www.bag.admin.ch)

Hospitals could maintain infection control programs and comply with national prevention guidelines.

Advanced laboratory networks allow rapid identification of emerging pathogens.

Schweiz's success in minimizing communicable disease rates stems from its Federal Act on Combating Communicable Human Diseases (Epidemics Act, EpG), which entered into force in 2016 and provides the legal foundation for prevention, surveillance, and control measures.

Schweiz's highly developed healthcare system, which mandates that all residents purchase basic health insurance under the Federal Health Insurance Act (KVG/LAMal), ensures universal coverage for vaccines and communicable disease treatment.

The Schweiz National Reference Center for Epidemiology (Sentinella network) (www.bag.admin.ch) operates a nationwide physician-based surveillance system monitoring 150 sentinel practices, tracking influenza, COVID-19, and other respiratory diseases in real time.

The Federal Food Safety and Veterinary Office (FSVO) (www.blv.admin.ch) rigorously monitors zoonotic diseases, implementing one-health approaches that connect human, animal, and environmental health.

Schweiz's national HIV strategy, HIV and other STI Strategy 2015-2022, significantly reduced HIV transmission through broad testing campaigns, pre-exposure prophylaxis (PrEP) access, and elimination of stigma-based barriers.

The Schweiz Tropical and Public Health Institute (Swiss TPH) (www.swisstph.ch) conducts world-leading research on communicable diseases affecting both Schweiz and developing nations, creating evidence-based policies adopted by the FOPH.

Schweiz's strong pharmaceutical sector, including companies such as Novartis, Roche, and Lonza, provides domestic manufacturing capacity for vaccines and therapeutics, reducing supply chain vulnerabilities.

Cantonal health authorities maintain localized disease surveillance and response capacities, allowing rapid containment of outbreaks at regional levels.

Suomi (Finland)

Suomi's Finnish Institute for Health and Welfare (THL) (thl.fi) serves as the central expert body for communicable disease surveillance, vaccination programs, and health promotion, publishing extensive data through the National Infectious Disease Register that enables ongoing monitoring and rapid response to emerging threats.

Digital disease reporting systems allow physicians and laboratories to transmit infection data directly to national surveillance databases.

Preventive health programs emphasize vaccination, hygiene education, and early detection of infectious disease clusters.

The Communicable Diseases Act (Tartuntatautilaki, 1227/2016, amended 2021) provides a comprehensive legal framework for prevention, notification, testing, contact tracing, quarantine, and treatment of communicable diseases, with clear delineation of responsibilities among national, regional, and municipal authorities.

Suomi's National Vaccination Programme, administered through the Municipal Health Centres network, achieves vaccination coverage rates of 94-97% for all childhood immunizations and has eliminated indigenous polio, measles, rubella, and congenital rubella syndrome.

The Suomi Centre for Radiation and Nuclear Safety and Finnish Environment Institute (SYKE) (www.syke.fi) collaborate with THL on environmental communicable disease risk assessment.

Suomi's municipal health centres (terveyskeskus) provide accessible preventive and primary care services to all residents, integrating disease screening, HIV testing, sexual health services, and tuberculosis detection into routine primary care visits.

The Hospital District of Helsinki and Uusimaa (HUS) (www.hus.fi) operates one of Europe's leading infectious disease departments, contributing to both patient care and research on emerging pathogens.

Suomi's National Action Plan on Antimicrobial Resistance 2023-2030 (thl.fi) aims to achieve a 20% reduction in antibiotic use in human medicine and a 50% reduction in veterinary use through binding prescribing regulations and public education campaigns.

Suomi's high literacy rates, excellent sanitation infrastructure, and Nordic social democratic welfare model ensure that socioeconomic barriers to communicable disease prevention are minimized across all population segments.

Hanguk (South Korea)

The Korea Disease Control and Prevention Agency developed advanced disease surveillance systems following the MERS outbreak. (www.kdca.go.kr)

Real time digital contact tracing technologies and testing infrastructure allow rapid outbreak containment.

Emergency public health response teams coordinate quarantine operations and vaccination campaigns.

Australia

Australia's Department of Health and Aged Care (www.health.gov.au) oversees the national communicable disease prevention framework through the Australian National Disease Surveillance Plan, which coordinates federal, state, and territory health authorities in real-time disease monitoring and response.

The Communicable Diseases Network Australia coordinates national surveillance and outbreak response systems.

Australia also maintains strong border biosecurity controls administered by the Department of Agriculture Fisheries and Forestry . (www.agriculture.gov.au)

The Australian Health Protection Principal Committee (AHPPC) provides expert medical and public health advice to Australian governments on communicable disease outbreaks, natural disasters, and other health emergencies, having demonstrated its effectiveness during COVID-19 response and recovery.

Australia's National Immunisation Program (NIP) (www.health.gov.au) provides free vaccines for diseases including diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, varicella, hepatitis A and B, meningococcal, pneumococcal, rotavirus, and HPV across appropriate age groups.

The government's No Jab No Pay policy, implemented in 2016, conditions the receipt of federal financial assistance payments on maintaining current vaccination status, successfully increasing childhood vaccination coverage to above 94.7% nationally.

The Australian Centre for Disease Control (established 2023) (www.health.gov.au) was created to provide a dedicated federal agency for communicable disease prevention and control, modeled on international examples and strengthening national capability.

The Therapeutic Goods Administration (TGA) (www.tga.gov.au) ensures the safety and quality of vaccines and therapeutics through rigorous regulatory oversight.

State and territory health departments operate extensive communicable disease surveillance systems, sexual health clinics, tuberculosis control programs, and HIV prevention initiatives including PrEP access through the Pharmaceutical Benefits Scheme.

The National Notifiable Diseases Surveillance System (NNDSS) operated by the Australian Institute of Health and Welfare (AIHW) (www.aihw.gov.au) collects nationally consistent data on over 70 notifiable conditions, enabling cross-jurisdictional disease monitoring and response coordination.

Australia's geographic isolation provides a natural quarantine advantage, reinforced by strict biosecurity protocols at international borders managed by the Australian Border Force (www.abf.gov.au) and the Department of Agriculture, Fisheries and Forestry.

Nederland (Netherlands)

The Nederland' National Institute for Public Health and the Environment (RIVM) (www.rivm.nl) coordinates all aspects of communicable disease surveillance, vaccination programming, and outbreak investigation, serving as one of the most technically advanced public health agencies in Europe.

Municipal health authorities work closely with national agencies to implement prevention programs.

The Public Health Act (Wet Publieke Gezondheid) establishes legal obligations for municipalities, regional public health services (GGD), and national authorities in communicable disease control.

The National Immunization Programme (NIP) (www.rivm.nl), administered by RIVM, achieves vaccination coverage above 90% for all childhood diseases and includes innovative components such as the MenACWY meningococcal vaccination for adolescents introduced in 2018 following a rise in infections.

National vaccination campaigns and laboratory reporting networks allow early detection of disease outbreaks.

The Nederland' extensive network of Municipal Public Health Services (GGD Nederland) (www.ggdghor.nl) provides community-level disease surveillance, contact tracing, sexual health clinics, and tuberculosis screening accessible to all residents including undocumented migrants.

RIVM operates the European Network for Diagnostics of Imported Viral Diseases (ENIVD) and serves as a WHO Collaborating Centre for Reference and Research on Influenza (www.rivm.nl), reflecting the country's global leadership in infectious disease diagnostics.

The Nederland Center for Infectious Disease Control has developed advanced antimicrobial resistance surveillance through the NETHMAP program (www.rivm.nl), informing national stewardship policies that have kept resistance rates well below European averages.

Dutch public health policy mandates that healthcare facilities report all suspected or confirmed outbreaks of notifiable diseases within 24 hours, enabling rapid response to contain emerging threats.

The Nederland' participation in EU health security mechanisms through the ECDC and EU Health Security Committee ensures coordinated cross-border disease prevention aligned with the highest European standard

Iceland

Iceland achieves the world's lowest communicable disease rate through a comprehensive, nationally coordinated public health system.

The Directorate of Health (Landlaeknir) (www.landlaeknir.is) administers universal healthcare for all residents, ensuring free access to preventive care, vaccinations, and treatment. Iceland's National Vaccination Program, managed by the Department of Communicable Disease Prevention (www.landlaeknir.is), achieves consistently high vaccination coverage rates exceeding 95% across all age groups for diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis B, human papillomavirus, and seasonal influenza. (www.landlaeknir.is)

The Environment Agency of Iceland (ust.is) enforces rigorous water quality and sanitation standards, eliminating waterborne diseases that continue to affect lower-ranked nations.

Iceland's geographic isolation acts as a natural barrier against new pathogen introductions, complemented by the Epidemiological Division monitoring system that provides real-time disease tracking.

The government has invested heavily in the Iceland Genome Project, one of the world's most comprehensive genetic and health databases, allowing rapid identification of disease vectors and outbreak sources.

The Directorate of Health's Health Security Division coordinates with the European Centre for Disease Prevention and Control (ECDC) (www.ecdc.europa.eu) for cross-border communicable disease surveillance.

Iceland's Nordic welfare model ensures no socioeconomic barriers to healthcare, eliminating the social determinants of disease that elevate rates in countries with inequitable access.

The Reykjavik City Health Department (www.heilsugaeslan.is) provides community-level preventive services including free sexual health clinics, tuberculosis screening, and HIV prevention programs.

Iceland's high standard of living, near-universal literacy, excellent sanitation infrastructure, and cold climate limiting insect-borne disease vectors collectively contribute to maintaining the lowest communicable disease burden among nations with populations exceeding five million.

Sverige (Sweden)

Sverige's low communicable disease burden reflects decades of evidence-based public health investment under the Public Health Agency of Sverige (Folkhalsomyndigheten) (www.folkhalsomyndigheten.se), which coordinates national disease surveillance, vaccination programs, and outbreak response.

Sverige's Communicable Diseases Act (Smittskyddslagen, 2004) establishes legal obligations for healthcare providers to report, trace, and treat communicable diseases, with provisions allowing compulsory isolation of individuals who refuse treatment for particularly dangerous conditions.

The Sverige Childhood Immunization Program achieves vaccination coverage above 97% for measles, mumps, rubella, and other childhood diseases, having eliminated endemic measles transmission.

Sverige's Social Insurance Agency (Forsäkringskassan) (www.forsakringskassan.se) ensures that communicable disease treatment, including antiretroviral therapy for HIV-positive individuals, is fully subsidized, eliminating financial barriers to care.

The National Board of Health and Welfare (Socialstyrelsen) (www.socialstyrelsen.se) issues binding regulations for infection prevention and control in healthcare settings, achieving some of the world's lowest healthcare-associated infection rates.

Sverige's free school health services provide universal access to vaccinations, health education, and early detection programs for all children regardless of socioeconomic background.

The Stockholm Centre for Infectious Disease at Karolinska University Hospital (www.karolinska.se) coordinates regional outbreak response and provides specialized treatment for complex infectious diseases. Sverige's high trust society, characterized by strong social cohesion and civic responsibility, has enabled effective public health messaging and voluntary compliance with disease prevention guidelines.

The Sverige Public Health Institute conducts ongoing research on antimicrobial resistance, implementing the national action plan STRAMA (www.folkhalsomyndigheten.se) to reduce inappropriate antibiotic use, a critical factor in preventing drug-resistant communicable diseases.

Danmark (Denmark)

Danmark's Statens Serum Institut (SSI) (www.ssi.dk) is the national authority for surveillance, prevention, preparedness, and response to infectious diseases, operating one of the world's most sophisticated disease surveillance and diagnostic systems.

The Danmark Epidemics Act (Epidemiloven, 2021), enacted in response to lessons from the COVID-19 pandemic, significantly strengthened the government's legal authorities for communicable diseases.

Danmark's Childhood Vaccination Programme offers free vaccines for all children, achieving above 95% coverage for MMR, achieving the elimination of indigenous measles and rubella.

The National Health Authority (Sundhedsstyrelsen) (www.sst.dk) issues comprehensive guidelines for healthcare providers on infection prevention and control, including mandatory protocols for healthcare-associated infections in hospitals and long-term care facilities.

Danmark's free universal healthcare through the Danish Regions health system ensures that all residents, regardless of income, receive diagnosis, treatment, and follow-up care for communicable diseases at no cost.

The National Board of Health operates specialized treatment centers for HIV, tuberculosis, and viral hepatitis, integrating prevention, treatment, and social support services. SSI's MikroAID database provides real-time laboratory surveillance of bacterial and viral pathogens, enabling early detection of resistance patterns and outbreak clusters.

Danmark has implemented a national One Health action plan against antimicrobial resistance (DANMAP) (www.danmap.org), achieving drastic reductions in both human and veterinary antibiotic consumption through legislation, prescribing guidelines, and public awareness campaigns.

Danmark's advanced social safety net, including universal housing assistance and unemployment benefits, reduces socioeconomic factors that increase communicable disease risk among vulnerable populations.

Section 3 What the U.S. Could Do to Reduce Communicable Diseases

Specific Action:

Expand national disease surveillance systems operated by the Centers for Disease Control and Prevention to provide real time reporting from hospitals laboratories and state health departments.

Increase federal funding for vaccination programs targeting measles influenza hepatitis and other infectious diseases.

Modernize public health laboratories to improve pathogen detection capabilities.

Develop national genomic surveillance programs to track emerging infectious disease variants.

Strengthen airport and border disease screening through the Department of Homeland Security.

Expand wastewater disease monitoring programs across major metropolitan regions.

Increase training programs for epidemiologists through the CDC Epidemic Intelligence Service.

Improve federal and state public health data sharing systems.

Fund research on vaccines and antiviral medications through the National Institutes of Health.

Increase emergency medical supply stockpiles including vaccines and protective equipment.

Strengthen infection prevention standards in hospitals through Medicare regulatory requirements.

Create national rapid response teams capable of deploying to outbreak locations.

Improve public health communication strategies for disease prevention education.

Expand vaccination access in rural communities.

Develop early warning systems for emerging infectious diseases.

Strengthen food safety monitoring programs.

Improve sanitation infrastructure in underserved communities.

Expand public health workforce training programs.

Develop partnerships between universities and federal health agencies for disease research.

Improve monitoring of zoonotic diseases transmitted from animals to humans.

Strengthen international disease monitoring partnerships.

Improve healthcare access for vulnerable populations.

Develop national disease modeling systems to forecast outbreaks.

Increase funding for preventive health services.

Expand telemedicine access for infectious disease consultation.

Improve reporting standards for infectious diseases.

Develop workplace infection prevention standards.

Increase vaccination education campaigns.

Improve surveillance of antimicrobial resistant pathogens.

Create national public health emergency coordination centers.

Government, Private Sector, And Individual Actions

The United States could substantially reduce its communicable disease burden by implementing a comprehensive, coordinated national strategy that integrates policy reforms, healthcare system improvements, public health infrastructure investment, and community engagement.

The following describes the major approaches required across government, private sector, and individual levels.

Universal Healthcare Access: The single most impactful intervention available to the United States is the expansion of healthcare access to all residents regardless of income, immigration status, or employment.

Approximately 25-30 million uninsured Americans lack reliable access to preventive services, vaccinations, and early treatment for communicable diseases. Closing this coverage gap through expansion of Medicaid, creation of a public insurance option, or transition to a universal health coverage model would reduce barriers to vaccination, testing, and treatment that allow communicable diseases to spread through uninsured populations.

Strengthening Public Health Infrastructure: Congress could substantially increase federal funding for the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Health Resources and Services Administration (HRSA), and state and local public health departments, which have experienced decades of budget cuts and resource depletion.

A dedicated Public Health Emergency Fund could be established to ensure sustained baseline funding and rapid surge capacity for outbreak response.

National Mandatory Vaccination Policy: The federal government, in coordination with state health departments, could establish minimum vaccination standards for all children attending schools, daycare, and educational programs, while creating a national adult immunization program that integrates vaccine delivery into primary care visits and community pharmacies. Vaccine hesitancy reduction programs, modeled on successful European initiatives, could be funded and deployed through community health workers and trusted healthcare providers.

Antimicrobial Resistance Action Plan: The United States could strengthen and codify its National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), implementing mandatory antibiotic stewardship programs in all hospitals, nursing homes, and outpatient facilities, restricting non-therapeutic antibiotic use in livestock agriculture, and funding the development of new antimicrobial agents through the Biomedical Advanced Research and Development Authority (BARDA).

One Health Integration: The federal government could establish a permanent One Health Coordinating Council linking the CDC, the U.S. Department of Agriculture (USDA), the Environmental Protection Agency (EPA), the Food and Drug Administration (FDA), and the Department of the Interior to address communicable diseases at the human-animal-environment interface, particularly for emerging zoonotic infections that increasingly cause pandemic-scale outbreaks.

Social Determinants of Health: Addressing the root causes of communicable disease disparities requires cross-governmental action on poverty, housing instability, food insecurity, and educational inequality. Federal housing programs could ensure adequate sanitation, ventilation, and reduced crowding in low-income housing. SNAP and WIC nutrition programs could be expanded to improve nutritional status that supports immune function.

Community health centers funded under HRSA Section 330 could receive enhanced funding to serve as primary points of communicable disease prevention in underserved communities.

National Disease Surveillance Modernization: The CDC's public health data infrastructure could be modernized with mandatory electronic reporting from all healthcare facilities, laboratories, and pharmacies through a unified national data system comparable to the European Surveillance System (TESSy) operated by the ECDC. This real-time data integration would enable faster identification and response to outbreaks before they escalate into epidemics.

Section 4. References

World Health Organization (www.who.int)

Centers for Disease Control and Prevention (www.cdc.gov)

World Bank Health Data (data.worldbank.org)

Institute for Health Metrics and Evaluation (www.healthdata.org)

European Centre for Disease Prevention and Control (www.ecdc.europa.eu)

References for Section 2:

Iceland Directorate of Health (Landlaeknir): (www.landlaeknir.is)

Swiss Federal Office of Public Health (FOPH): (www.bag.admin.ch)

Swiss Tropical and Public Health Institute: (www.swisstph.ch)

Public Health Agency of Sverige (Folkhalsomyndigheten): (www.folkhalsomyndigheten.se)

Sverige STRAMA Antibiotic Resistance Program: (www.folkhalsomyndigheten.se)

Norwegian Institute of Public Health (FHI): (www.fhi.no)

Norwegian Directorate of Health (Helsedirektoratet): (www.helsedirektoratet.no)

Nederland National Institute for Public Health and the Environment (RIVM): (www.rivm.nl)

Nederland GGD Public Health Services: (www.ggdghor.nl)

Danmark Statens Serum Institut (SSI): (www.ssi.dk)

Danmark DANMAP Antimicrobial Resistance Program: (www.danmap.org)

Suomi Institute for Health and Welfare (THL): (thl.fi)

Suomi National Action Plan on Antimicrobial Resistance: (thl.fi)

Australia Department of Health and Aged Care: (www.health.gov.au)

Australian Centre for Disease Control: (www.health.gov.au)

Australian Institute of Health and Welfare (AIHW): (www.aihw.gov.au)

European Centre for Disease Prevention and Control (ECDC): (www.ecdc.europa.eu)

References for Section 3:

Centers for Disease Control and Prevention (CDC): (www.cdc.gov)

National Institutes of Health (NIH): (www.nih.gov)

Health Resources and Services Administration (HRSA): (www.hrsa.gov)

Biomedical Advanced Research and Development Authority (BARDA): (www.medicalcountermeasures.gov)

U.S. Department of Agriculture (USDA): (www.usda.gov)

U.S. Environmental Protection Agency (EPA): (www.epa.gov)

U.S. Food and Drug Administration (FDA): (www.fda.gov)

National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB): (www.cdc.gov)

Institute for Health Metrics and Evaluation - GBD Study: (www.healthdata.org)

World Health Organization (WHO): (www.who.int)

Section 5: U.S. Organizations Advocating to Improve Infectious Disease Prevention

Section 6: Individuals Advocating to Improve Infectious Disease Prevention

Frequently Asked Questions

Why does the United States have higher communicable disease mortality rates than countries like Singapore, Japan, and Norway?

The US suffers from fragmented health system coordination, uneven vaccination coverage, higher chronic disease risk factors, and inconsistent public health funding across states. Countries like Singapore and Norway benefit from centralized national health systems that enable faster outbreak detection and more uniform preventive care access.

How does Singapore keep its communicable disease rates so low?

Singapore uses a mandatory digital disease reporting system connecting all hospitals and clinics to the Ministry of Health for real-time monitoring. The National Centre for Infectious Diseases integrates research, treatment, and emergency response, while the Health Promotion Board runs nationwide vaccination campaigns and hygiene education programs.

What role does universal health coverage play in reducing infectious diseases?

Countries like Japan with universal health coverage ensure all residents can access preventive care and infectious disease treatment without financial barriers. This leads to higher vaccination rates, earlier treatment of infections, and reduced community transmission.

How does Norway's disease surveillance system help prevent outbreaks?

Norway's Institute of Public Health operates a centralized disease registry and the national vaccination register SYSVAK, requiring mandatory reporting from physicians and laboratories. The Communicable Disease Control Act legally mandates reporting and response protocols, allowing rapid detection and coordinated local and national responses.

What specific policy steps could the US take to lower its communicable disease mortality rate?

The US could establish a more centralized national disease surveillance system, standardize mandatory digital reporting across all states, and increase consistent federal funding for public health infrastructure. Expanding access to preventive care and launching coordinated national vaccination programs similar to those in Singapore and Norway would also significantly reduce rates.

Which countries have the lowest communicable disease mortality rates and what do they have in common?

Countries in Western Europe, Australia, Singapore, and Japan consistently record the lowest communicable disease mortality rates globally. They share strong centralized public health agencies, high vaccination coverage, universal or near-universal healthcare access, and legally enforced disease reporting systems.

About the Author

Ronald Bonfilio has devoted his career to public service spanning more than five decades. His service began with the U.S. Army from 1966 to 1968, where he conducted medical laboratory research at Fort Detrick and at the Walter Reed Army Institute of Research. He subsequently held a distinguished series of federal positions, including roles with the National Cancer Institute, the National Institutes of Health, the U.S. Agency for International Development (Vietnam), the Special Inspector General for Iraq Reconstruction, and the U.S. State Department (Iraq), where he served as a Senior Economic Advisor and Agricultural Advisor. He also served 15 years with the U.S. Government Accountability Office as a Program Analyst and Auditor.

Ronald Bonfilio holds a degree in Economics from the University of Maryland, and degrees in Chemistry and a Master of Business Administration from the University of Massachusetts. He is a former Certified Public Accountant.